GCP
RBOT

GSA Capital Partners’s Vicarious Surgical RBOT Stock Holding History

GSA Capital Partners’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-504
Closed -$9K – 1850
2023
Q3 		$9K Buy
+504
New +$18.4K ﹤0.01% 1436
2023
Q1 		– Sell
-679
Closed -$41K – 1855
2022
Q4 		$41K Buy
+679
New +$63.1K 0.01% 1366

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

GSA Capital Partners's RBOT Position: Q4 2023 in Review

GSA Capital Partners sold out of Vicarious Surgical (RBOT) in Q4 2023, closing a stake of 504 shares — an estimated $9K sold.

GSA Capital Partners first reported a position in RBOT in Q4 2022 and held it in 2 quarters. The position peaked at $41K in Q4 2022. 72 funds tracked by Wall St. Rank hold RBOT as of Q4 2023.

  • GSA Capital Partners reported no remaining Vicarious Surgical position as of Q4 2023 after selling out during the quarter.
  • GSA Capital Partners sold 504 Vicarious Surgical shares in Q4 2023, an estimated $9K.
  • GSA Capital Partners first reported a position in Vicarious Surgical in Q4 2022 and held it in 2 quarters.
  • GSA Capital Partners's Vicarious Surgical position peaked at $41K in Q4 2022.
  • 72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2023.

Based on GSA Capital Partners's 13F filing for Q4 2023, filed 16 Feb 2024.